Amplification of sex repressor function of one fi-+ R-factor during anaerobic growth of Escherichia coli.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 235715)

Published in J Bacteriol on July 01, 1975

Authors

L G Burman

Articles cited by this

Acetylornithinase of Escherichia coli: partial purification and some properties. J Biol Chem (1956) 93.84

Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol (1951) 28.27

Formation of merodiploids in matings with a class of Rec- recipient strains of Escherichia coli K12. Proc Natl Acad Sci U S A (1968) 15.37

Non-chromosomal antibiotic resistance in bacteria. II. Molecular nature of R-factors isolated from Proteus mirabilis and Escherichia coli. J Mol Biol (1970) 11.86

Mutant drug resistant factors of high transmissibility. Nature (1967) 9.87

Phylogenetic relationships of drug-resistance factors and other transmissible bacterial plasmids. Bacteriol Rev (1968) 9.19

Anaerobic bacteria of the gastrointestinal flora and their occurrence in clinical infections. J Infect Dis (1969) 6.07

Early stages of conjugation in Escherichia coli. J Bacteriol (1969) 4.08

Some observations on linkage effects in genetic recombination in Escherichia coli K-12. J Gen Microbiol (1954) 3.26

Resistance of Escherichia coli to Penicillins I. Genetic Study of Some Ampicillin-Resistant Mutants. J Bacteriol (1965) 2.81

The relationship of F type piliation and F phage sensitivity to drug resistance transfer in R+F- Escherichia coli K 12. J Gen Microbiol (1966) 2.52

Functional homology of the sex-factor and resistance transfer factors. Nature (1965) 2.37

EPISOME-MEDIATED TRANSFER OF DRUG RESISTANCE IN ENTEROBACTERIACEAE. VI. HIGH-FREQUENCY RESISTANCE TRANSFER SYSTEM IN ESCHERICHIA COLI. J Bacteriol (1963) 1.46

Investigations on the influence of diet on the quantity and composition of intestinal gas in humans. Scand J Clin Lab Invest (1956) 0.99

Articles by these authors

(truncated to the top 100)

Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother (1977) 3.32

Resistance of Escherichia coli to penicillins. V. Physiological comparison of two isogenic strains, one with chromosomally and one with episomally mediated ampicillin resistance. J Bacteriol (1968) 2.27

Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet (1989) 2.11

Molecular model for elongation of the murein sacculus of Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.97

Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol (1977) 1.96

Colicin tolerance induced by ampicillin or mutation to ampicillin resistance in a strain of Escherichia coli K-12. J Bacteriol (1971) 1.96

Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95

A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84

Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis (1991) 1.75

Evidence for diffuse growth of the cylindrical portion of the Escherichia coli murein sacculus. J Bacteriol (1983) 1.71

Autolysis of Neisseria gonorrhoeae. J Bacteriol (1976) 1.65

Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62

Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology (1999) 1.61

Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J Bacteriol (1970) 1.52

Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J Bacteriol (1973) 1.49

Correlation between surface and air counts of particles carrying aerobic bacteria in operating rooms with turbulent ventilation: an experimental study. J Hosp Infect (1999) 1.45

Changes in the composition of Escherichia coli murein as it ages during exponential growth. J Bacteriol (1983) 1.43

Relation between nursing procedures, other local characteristics and transmission of enteric bacteria in neonatal wards. J Hosp Infect (1993) 1.39

Biochemical fingerprinting compared with ribotyping and pulsed-field gel electrophoresis of DNA for epidemiological typing of enterococci. J Clin Microbiol (1995) 1.38

Evidence for multisite growth of Escherichia coli murein involving concomitant endopeptidase and transpeptidase activities. J Bacteriol (1983) 1.38

Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol (1988) 1.36

Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb Drug Resist (2003) 1.25

Time- and media-saving testing and identification of microorganisms by multipoint inoculation on undivided agar plates. J Clin Microbiol (1978) 1.25

Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25

Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun (2000) 1.23

An allelic variant of the chromosomal gene for class A beta-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob Agents Chemother (1997) 1.12

In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect (2009) 1.12

Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10

Molecular cloning in streptococci: physical mapping of the vehicle plasmid pSM10 and demonstration of intergroup DNA transfer. Mol Gen Genet (1981) 1.06

R-plasmid transfer and its response to nalidixic acid. J Bacteriol (1977) 1.04

Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol (1999) 1.00

Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli. J Med Microbiol (1992) 0.99

Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol (1992) 0.99

The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards. J Hosp Infect (1993) 0.98

Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis (1988) 0.98

Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect (1988) 0.97

Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward. Epidemiol Infect (1990) 0.96

Elongation of the murein sacculus of Escherichia coli. Ann Inst Pasteur Microbiol (1985) 0.93

Nationwide spread of Klebsiella oxytoca K55 in Swedish neonatal special care wards. APMIS (1992) 0.93

Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme. Int J Antimicrob Agents (2000) 0.92

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother (1987) 0.92

Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile. J Hosp Infect (2003) 0.91

Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Urol (1997) 0.91

Expression of R-plasmid functions during anaerobic growth of an Escherichia coli K-12 host. J Bacteriol (1977) 0.90

Urinary tract infection in primary health care in northern Sweden. I. Epidemiology. Scand J Prim Health Care (1987) 0.90

Recurrent pneumonia and encephalitis due to Mycoplasma pneumoniae. Scand J Infect Dis (1979) 0.90

Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88

Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol (1994) 0.87

A 7-year survey of drug resistance in aerobic and anaerobic fecal bacteria of surgical inpatients: clinical relevance and relation to local antibiotic consumption. Scand J Infect Dis (1989) 0.87

Urinary tract infection in primary health care in northern Sweden. II. Clinical presentation. Scand J Prim Health Care (1987) 0.86

Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Antimicrob Agents Chemother (2006) 0.85

Pathogenesis of Escherichia coli cystitis and pyelonephritis: apparent lack of significance of bacterial motility and chemotaxis towards human urine. Infection (1985) 0.85

Influence of antibiotic therapy on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in neonates. J Antimicrob Chemother (1988) 0.85

Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime. Antimicrob Agents Chemother (1990) 0.85

Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up. Pediatr Radiol (1994) 0.85

Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.85

Efficient transfer of conjugative plasmids by multipoint inoculation and some observations on host range and prevalence of R plasmids. Plasmid (1978) 0.84

Transmission of urinary bacterial strains between patients with indwelling catheters--nursing in the same room and in separate rooms compared. J Hosp Infect (1997) 0.84

Importance of the environment and the faecal flora of infants, nursing staff and parents as sources of gram-negative bacteria colonizing newborns in three neonatal wards. Infection (1992) 0.84

Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand (2002) 0.83

Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol Scand (2007) 0.83

Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit. Acta Paediatr (1998) 0.83

Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations. Scand J Infect Dis (1986) 0.83

Urinary tract infection in primary health care in northern Sweden. III. Bacteriology in relation to clinical and epidemiological factors. Scand J Prim Health Care (1987) 0.82

Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin Microbiol Infect (2003) 0.82

Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile. Antimicrob Agents Chemother (2007) 0.82

Uricult and Sensicult dipslides for diagnosis of bacteriuria and prediction of drug resistance in primary health care. Scand J Prim Health Care (1989) 0.82

Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring. Acta Paediatr (1996) 0.82

Single-dose intravenous metronidazole v. doxycycline prophylaxis in colorectal surgery. An open prospective, randomized trial. Acta Chir Scand (1985) 0.81

Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Acta Paediatr Scand (1991) 0.81

Epidemiology of enteric bacteria in neonatal units--influence of procedures and patient variables. J Hosp Infect (1991) 0.81

Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. J Urol (2000) 0.81

Antibiotic consumption and faecal bacterial susceptibility in surgical in-patients. Acta Chir Scand (1987) 0.80

The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards. Epidemiol Infect (1991) 0.80

Interleukin-1 alpha and interleukin-6 in the urine, kidney, and bladder of mice inoculated with Escherichia coli. Pediatr Nephrol (1996) 0.80

Streptococcus pneumoniae and three species of anaerobic bacteria in experimental otitis media in guniea pigs. J Infect Dis (1982) 0.79

Outbreak of infections due to P-fimbriated Escherichia coli O16:K1 in a neonatal intensive care unit. Acta Paediatr Scand (1988) 0.79

Zoned vertical ultraclean operating room ventilation. A novel concept making long side walls unnecessary. Acta Orthop Scand (1996) 0.79

Prevention of post-operative infection in appendicectomy by single dose intravenous metronidazole. An open prospective randomised study. Acta Chir Scand (1985) 0.79

Serum and tissue pharmacokinetics of intravenous metronidazole in surgical patients. Acta Chir Scand (1989) 0.79

[Registration of surgical infections can save multimillions in health care]. Lakartidningen (1985) 0.79

Surgical area contamination--comparable bacterial counts using disposable head and mask and helmet aspirator system, but dramatic increase upon omission of head-gear: an experimental study in horizontal laminar air-flow. J Hosp Infect (2001) 0.79

Further bacteriological evaluation of the TOUL mobile system delivering ultra-clean air over surgical patients and instruments. J Hosp Infect (2006) 0.78

Short-term nalidixic acid plus sodium citrate in acute lower urinary tract infection. Scand J Infect Dis (1987) 0.78

Optimized urinary microscopy for assessment of bacteriuria in primary care. J Fam Pract (1990) 0.78

Zoned exponential, vertical and horizontal ultra-clean laminar airflows. No differences in bacteriological efficiency. Acta Orthop Scand (1998) 0.78

The antimicrobial activities of trimethoprim and sulfonamides. Scand J Infect Dis (1986) 0.77

Correlation between susceptibility of infants to infections and interaction with neutrophils of Escherichia coli strains causing neonatal and infantile septicemia. J Infect Dis (1995) 0.77

Introducing fosfomycin for surgical prophylaxis--emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures. Scand J Infect Dis (1993) 0.77

Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: a seven year follow-up study including loracarbef. Swedish Respiratory Tract Study Group. Scand J Infect Dis (1992) 0.77

Association between climate and Enterobacter colonization in Swedish neonatal units. Infect Control Hosp Epidemiol (1993) 0.76

Inconsistent correlation between aerobic bacterial surface and air counts in operating rooms with ultra clean laminar air flows: proposal of a new bacteriological standard for surface contamination. J Hosp Infect (1999) 0.76

Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. A randomised double-blind multicentre trial in 517 patients. Eur J Surg (1992) 0.76

Survival on skin and surfaces of epidemic and non-epidemic strains of enterobacteria from neonatal special care units. J Hosp Infect (1995) 0.75

Influence on motility of Escherichia coli and Salmonella typhimurium by a naturally occurring conjugative plasmid. J Bacteriol (1977) 0.75

[Uncomplicated lower urinary tract infection: 3-day therapy is recommended!]. Lakartidningen (1999) 0.75

[DNA-damaging agents: the greatest health threat of our time?]. Lakartidningen (1979) 0.75

[Prevention of nosocomial urinary tract infection]. Lakartidningen (1984) 0.75

[Choice of antibiotics in uterine tract infections--the pendulum shifts back. Pivmecillinam is going to take back its role as the first choice preparation]. Lakartidningen (1999) 0.75

[Antibiotic resistance of urinary tract infections in Sweden, 1976]. Lakartidningen (1979) 0.75